January 11, 2017
The acquisition of US cancer drug maker Ariad Pharmaceuticals is a global one that is not limited to the US market, Takeda Pharmaceutical CEO Christophe Weber said on January 10, expressing his company’s readiness for the launch of Ariad products...read more